About

Publications While At HealthPartners

selected publications

Journal Article

DURATION-2: efficacy and safety of switching from maximum daily sitagliptin or pioglitazone to once-weekly exenatide. 

Diabetic Medicine. 2011

Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial. 

Lancet (London, England). 2010

Contact

full name

J. Malone

Quick Info

Publications

Publications in the past 10 years based solely on publications while at HealthPartners. Publications in prior years appear in grey.

Collaboration

Co-author network

Map of science